Fatal Left Ventricular Thrombosis in an Infant ReceivingExtracorporeal Membrane Oxygenation Support -A Case Report-

다국어 초록 (Multilingual Abstract)

Thromboembolism in patients receiving extracorporeal membrane oxygenation (ECMO) support is a feared complication. Systemic anticoagulation during ECMO in patients with a massively dilated left ventricle (LV) and decreased LV systolic function is still debated. Hearin, we report a case of a 5-month old infant on ECMO support who had fatal thrombus formation in the massively dilated LV and a consequent thromboembolic event.

참고문헌 (Reference)

1 제형곤, "중환자실에서 체외막형 산소섭취의 현재와 미래" 대한중환자의학회 26 (26): 51-56, 2011

2 Ward KE, "Transseptal decompression of the left heart during ECMO for severe myocarditis" 59 : 749-751, 1995

3 De Waele JJ, "The use of the activated clotting time for monitoring heparin therapy in critically ill patients" 29 : 325-328, 2003

4 Koster A, "The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass : a pilot investigation" 95 : 26-30, 2002

5 Jouan J, "Successful left ventricular decompression following peripheral extracorporeal membrane oxygenation by percutaneous placement of a micro-axial flow pump" 29 : 135-136, 2010

6 Bakalli A, "Prevalence of left chamber cardiac thrombi in patients with dilated left ventricle at sinus rhythm: the role of transesophageal echocardiography" 41 : 38-45, 2013

7 Teele SA, "Management and outcomes in pediatric patients presenting with acute fulminant myocarditis" 158 : 638-643, 2011

8 Raymond PD, "Heparin monitoring during cardiac surgery. Part 2: Calculating the overestimation of heparin by the activated clotting time" 18 : 277-281, 2003

9 Lip GY, "ESC Task Force: Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis" 14 : 681-695, 2012

10 Fries D, "Coagulation monitoring and management of anticoagulation during cardiac assist device support" 76 : 1593-1597, 2003

11 Muntean W, "Coagulation and anticoagulation in extracorporeal membrane oxygenation" 23 : 979-983, 1999

12 Messika-Zeitoun D, "Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications" 47 : 2521-2527, 2006

13 Nagaya M, "Application of a new anticoagulant (Nafamostat Mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation--a preliminary report" 32 : 531-535, 1997

14 Spanier T, "Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices" 112 : 1090-1097, 1996